The Clinical Validity of Urinary Pellet DNA Monitoring for the Diagnosis of Recurrent Bladder Cancer.
Abe M, Hiraki H, Tsuyukubo T, Ono S, Maekawa S, Tamura D, Yashima-Abo A, Kato R, Fujisawa H, Iwaya T, Park WY, Idogawa M, Tokino T, Obara W, Nishizuka SS.
Abe M, et al. Among authors: kato r.
J Mol Diagn. 2024 Apr;26(4):278-291. doi: 10.1016/j.jmoldx.2024.01.006. Epub 2024 Feb 1.
J Mol Diagn. 2024.
PMID: 38301868
Free article.